NASDAQ:EVLV Stock Report
Market Cap $925.47M
$5.30
-1.12%
-$0.06 today
Market Cap
$925.47M
P/E Ratio
N/A
Sector: 42.29
EPS
-$0.01
Volume
1.9M
Year High
$8.91
Year Low
$2.64
50-Day MA
Below$6.29
200-Day MA
Below$6.70
Evolv Technologies Holdings, Inc. provides artificial intelligence (AI)-based touchless security screening systems. Its products include Evolv Express, a touchless security screening system designed to detect firearms, improvised explosive devices, and tactical knives as visitors walk through at a normal pace; Evolv Insights that provides self-serve access, insights regarding visitor flow and arrival curves, location specific performance, system detection performance, and alarm statistics; and Evolv Edge to detect non-metallic explosive devices, explosive devices, firearms, and tactical knives without requiring visitors to divest or empty their pockets. The company is headquartered in Waltham, Massachusetts.
Evolv Technologies Holdings, Inc. (EVLV) is positioned as a leading provider of AI-powered weapons detection and security screening systems, currently trading at $5.36 with a market sentiment strongly favoring a buy rating. The stock has demonstrated strong recent performance, supported by a 56.62% year-over-year revenue increase in Q3 2025 and a consensus analyst price target of $10.00, indicating nearly 87% upside potential. Analyst upgrades from firms such as Lake Street and Northland Capital Markets reinforce the positive outlook, reflecting growing confidence in the company’s operational execution and market expansion. Key developments include Evolv’s selection as the preferred physical security provider by the American Hospital Association, a significant endorsement that opens substantial revenue opportunities in the healthcare sector. Additionally, multi-year contracts with major sports venues like Shell Energy Stadium and Miami Freedom Park highlight the company’s expanding footprint in large-scale venue security, supporting recurring revenue growth. Governance improvements, such as the appointment of an independent director with financial expertise, further strengthen the company’s oversight. While the company benefits from strong growth drivers including increasing adoption of AI-driven security solutions, a subscription-based revenue model, and key designations from the U.S. Department of Homeland Security, it faces challenges. These include execution risks inherent in scaling a hardware-plus-software business, ongoing net losses due to heavy R&D and sales investments, and regulatory and competitive pressures. Macro risks such as economic slowdowns and financing costs also pose potential headwinds. Looking forward, the upcoming Q4 2025 earnings release scheduled for March 10, 2026, will be a critical event for investors to assess Evolv’s progress toward profitability and margin expansion. The company’s strategic positioning in growing security markets, combined with its technological leadership and expanding customer base, supports a constructive long-term outlook despite near-term risks.
Price Target
7 analysts$10.00
Range: $10.00
→
$10.00
Upside Potential
+88.7%
From current price
Consensus Rating
Rating Distribution
Buy
Hold
Evolv Technologies benefits from a robust set of positive catalysts that underpin its bullish outlook. The company’s strong revenue growth, exemplified by a 56.62% year-over-year increase in Q3 2025, reflects accelerating demand for its AI-powered security screening solutions. This growth is further supported by significant contract wins, including its designation as the American Hospital Association’s preferred physical security provider, which opens a large and expanding healthcare market. Additionally, multi-year agreements with prominent sports venues such as Shell Energy Stadium and Miami Freedom Park enhance recurring revenue streams and brand visibility in high-profile settings. Analyst sentiment is overwhelmingly positive, with a consensus Buy rating and a unified price target of $10.00, implying nearly 87% upside from the current price. Recent upgrades by Lake Street and Northland Capital Markets signal increasing confidence in the company’s execution and growth prospects. Evolv’s subscription-based business model, combined with its SAFETY Act Designation from the U.S. Department of Homeland Security, provides competitive advantages by validating its technology’s efficacy and supporting customer trust. Looking ahead, the upcoming Q4 2025 earnings release is anticipated to provide further clarity on the company’s path to profitability and margin expansion. The company’s focus on innovation, strategic partnerships, and expanding adoption across diverse sectors such as healthcare, sports, education, and public spaces positions it well to capitalize on growing security needs globally.
Despite its promising growth trajectory, Evolv faces several material risks that could impact its stock performance. The company continues to operate at a net loss due to substantial investments in research and development, sales, and manufacturing, necessitating ongoing capital raises that may dilute shareholders. Execution risks are significant given the complexity of scaling a hardware-plus-software business in a highly regulated and safety-critical market. Lengthening sales cycles, regulatory scrutiny, and pricing pressures, particularly in the education sector, add to near-term revenue uncertainties. Industry-wide regulatory and privacy concerns pose additional challenges, as changes in U.S. security and procurement rules could increase compliance costs or limit product adoption. The competitive landscape is intensifying with both traditional security firms and emerging AI-driven entrants vying for market share, which may pressure margins and growth. Macro risks such as potential economic slowdowns and rising interest rates could reduce customer capital spending and increase financing costs, further complicating the company’s path to profitability. Technical indicators also suggest elevated stock volatility and bearish trading trends, with no strong support levels below current prices, which may increase downside risk. Investors should remain cautious about valuation expectations, as failure to meet margin improvement and profitability targets could trigger negative market reactions.
Explore similar companies in the Industrials sector